These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7695338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The intestinal elimination of ciprofloxacin in the rat.
    Rubinstein E, St Julien L, Ramon J, Dautrey S, Farinotti R, Huneau JF, Carbon C.
    J Infect Dis; 1994 Jan; 169(1):218-21. PubMed ID: 8277187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
    Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
    de Lange EC, Marchand S, van den Berg D, van der Sandt IC, de Boer AG, Delon A, Bouquet S, Couet W.
    Eur J Pharm Sci; 2000 Dec; 12(2):85-93. PubMed ID: 11102735
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of cholera toxin on intestinal elimination of ciprofloxacin in rabbits.
    Musafija A, Barzilai A, Ramon J, Rubinstein E.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):473-4. PubMed ID: 9527813
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activity of sparfloxacin against experimental renal infections in mice.
    Georgopoulos A, Feistauer SM, Graninger W, Pfleger S, Georgopoulos M.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):505-7. PubMed ID: 1318685
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
    Chukwuani CM, Coker HA, Oduola AM, Sowunmi A, Ifudu ND.
    Biol Pharm Bull; 2000 Aug; 23(8):968-72. PubMed ID: 10963305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.